News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
143 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (176)
2 (7)
3 (6)
4 (219)
5 (189)
6 (212)
7 (230)
8 (95)
9 (2)
10 (7)
11 (143)
12 (249)
13 (209)
14 (213)
15 (105)
16 (3)
17 (5)
18 (200)
19 (228)
20 (201)
21 (239)
22 (96)
23 (3)
24 (6)
25 (203)
26 (268)
27 (220)
28 (279)
29 (127)
30 (2)
31 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Genetown
Protalix Biotherapeutics and Chiesi Global Rare Diseases Provide Regulatory Update on PRX-102 for the Treatment of Fabry Disease
Protalix BioTherapeutics, Inc. and Chiesi Global Rare Diseases provided a regulatory update regarding pegunigalsidase alfa for the proposed treatment of Fabry disease which included an announcement of the receipt of the official Type A meeting minutes from the U.S. FDA regarding the Complete Response Letter received for the PRX–102 Biologics License Application confirming a potential pathway for resubmission of a BLA for PRX–102.
October 11, 2021
·
10 min read
Business
Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results
Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, November 2, 2021 , at 8:00 a.m. CDT to review first quarter 2022 financial results.
October 11, 2021
·
2 min read
Biotech Bay
Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression
Koya Medical recently presented data from the company’s prospective, multi-center, randomized, crossover study (NILE – NCT04908254) comparing Dayspring®, the company’s active compression treatment for lymphedema, to a traditional pneumatic compression pump.
October 11, 2021
·
5 min read
Business
Horizon Therapeutics plc to Release Third-Quarter 2021 Financial Results and Host Webcast on Nov. 3, 2021
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its third-quarter 2021 financial results will be released on Wednesday, Nov. 3, 2021.
October 11, 2021
·
1 min read
Business
Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid Cancers
Kiromic BioPharma, Inc. announces it has engaged in a strategic collaboration with Gemelli Teaching Hospital IRCCS to accelerate the analysis of the Company’s first allogeneic CAR-T clinical trial candidate Alexis ISO-1.
October 11, 2021
·
6 min read
Revance Announces the Launch of OPUL™, the First-of-its-Kind Relational Commerce Platform for Aesthetic Practices
Revance Announces the Launch of OPUL ™ , the First-of-its-Kind Relational Commerce Platform for Aesthetic Practices
October 11, 2021
·
8 min read
Biotech Bay
Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment
Veracyte, Inc . (Nasdaq: VCYT) today announced that new expanded clinical validation data reinforce the ability of the company’s noninvasive Percepta Nasal Swab test to help physicians more accurately assess lung cancer risk in patients with lung nodules.
October 11, 2021
·
8 min read
Business
ChemoCentryx Appoints Rita I. Jain, M.D. as Executive Vice President, Chief Medical Officer
ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the appointment of Rita I. Jain, M.D., as Executive Vice President, Chief Medical Officer.
October 11, 2021
·
3 min read
Lone Star Bio
Natera Announces New Publication Validating Signatera® Velocity Metric to Improve Cancer Management
Peer-reviewed study in stage III colorectal cancer demonstrates the prognostic value of ctDNA growth rate as measured by Signatera in over 1200 plasma samples
October 11, 2021
·
6 min read
Biotech Beach
Allergan Aesthetics Launches Series of Initiatives to Support Breast Cancer Awareness
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is continuing its commitment to breast health, awareness, restoration, and research in support of breast cancer awareness month.
October 11, 2021
·
4 min read
Previous
11 of 15
Next